InterCure Ltd. (INCR)
Largest Insider Buys in Sector
INCR Stock Price History Chart
INCR Stock Performance
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
Insider Activity of InterCure Ltd.
Over the last 12 months, insiders at InterCure Ltd. have bought $0 and sold $0 worth of InterCure Ltd. stock.
On average, over the past 5 years, insiders at InterCure Ltd. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $43,187 was made by Burgstahler David F () on 2016‑09‑19.
List of Insider Buy and Sell Transactions, InterCure Ltd.
| 2017-09-18 | Sale | Chief Financial Officer | 9,703 0.8684% | $54.48 | $528,600 | -19.43% | ||
| 2017-09-18 | Sale | CAO, GC & Sec | 4,682 0.4196% | $54.55 | $255,427 | -19.43% | ||
| 2017-09-01 | Sale | Chief Financial Officer | 88,739 8.5995% | $58.99 | $5.23M | -11.52% | ||
| 2017-09-01 | Sale | CAO, GC & Sec | 42,601 4.1062% | $58.67 | $2.5M | -11.52% | ||
| 2017-08-30 | Sale | Chief Financial Officer | 41,420 3.9647% | $58.26 | $2.41M | -10.37% | ||
| 2017-07-03 | Sale | CAO, GC & Sec | 956 0.092% | $58.55 | $55,974 | +18095.49% | ||
| 2017-06-30 | Sale | CAO, GC & Sec | 5,917 0.5666% | $58.28 | $344,872 | +18095.49% | ||
| 2017-04-03 | Sale | CAO, GC & Sec | 4,733 0.3554% | $45.70 | $216,298 | +18095.49% | ||
| 2017-01-20 | Sale | Executive VP and CFO | 1,573 0.1305% | $50.50 | $79,437 | +18095.49% | ||
| 2017-01-20 | Sale | CAO, GC & Sec | 1,186 0.0976% | $50.09 | $59,406 | +18095.49% | ||
| 2017-01-19 | Sale | Executive VP and CFO | 1,334 0.111% | $50.65 | $67,567 | +18095.49% | ||
| 2017-01-03 | Sale | Executive VP and CFO | 41,420 3.5319% | $51.90 | $2.15M | +18112.20% | ||
| 2017-01-03 | Sale | CAO, GC & Sec | 15,383 1.3117% | $51.90 | $798,420 | +18112.20% | ||
| 2016-09-30 | Sale | Executive VP and CFO | 35,503 2.6071% | $44.70 | $1.59M | +18438.01% | ||
| 2016-09-27 | Sale | Chief Executive Officer | 53,970 3.9283% | $44.30 | $2.39M | +18446.37% | ||
| 2016-09-26 | Sale | director | 12,197 0.8849% | $44.16 | $538,625 | +18446.37% | ||
| 2016-09-19 | 1,000 0.071% | $43.19 | $43,187 | +18529.91% | ||||
| 2016-09-14 | Sale | CAO, GC & Sec | 4,734 0.3355% | $43.14 | $204,234 | +18563.32% | ||
| 2016-08-04 | Sale | 2.45M – | $42.06 | $102.86M | +18446.37% | |||
| 2016-08-02 | Sale | Chief Executive Officer | 31,279 2.2097% | $43.00 | $1.34M | +18563.32% |